Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

The role of calprotectin in pediatric disease.

Vaos G, Kostakis ID, Zavras N, Chatzemichael A.

Biomed Res Int. 2013;2013:542363. doi: 10.1155/2013/542363. Epub 2013 Sep 23. Review.

2.

[Research advances in the role of fecal calprotectin in intestinal development and diseases among children].

Li F, Sheng XY.

Zhongguo Dang Dai Er Ke Za Zhi. 2014 Oct;16(10):1064-9. Review. Chinese.

3.
4.

Increased fecal calprotectin in preterm infants with necrotizing enterocolitis.

Aydemir G, Cekmez F, Tanju IA, Canpolat FE, Genc FA, Yildirim S, Tunc T, Sarici SU.

Clin Lab. 2012;58(7-8):841-4.

PMID:
22997988
5.

Serum calprotectin: review of its usefulness and validity in paediatric rheumatic diseases.

Mariani A, Marsili M, Nozzi M, Faricelli R, Chiarelli F, Breda L.

Clin Exp Rheumatol. 2015 Jan-Feb;33(1):109-14. Epub 2014 Dec 22. Review.

PMID:
25535818
6.

Severe anemia and neutropenia associated with hyperzincemia and hypercalprotectinemia.

Fessatou S, Fagerhol MK, Roth J, Stamoulakatou A, Kitra V, Hadarean M, Paleologos G, Chandrinou H, Sampson B, Papassotiriou I.

J Pediatr Hematol Oncol. 2005 Sep;27(9):477-80.

PMID:
16189440
7.

S100 Calgranulins in inflammatory arthritis.

Perera C, McNeil HP, Geczy CL.

Immunol Cell Biol. 2010 Jan;88(1):41-9. doi: 10.1038/icb.2009.88. Epub 2009 Nov 24. Review.

PMID:
19935766
8.

[Pediatrics. Fecal calprotectin in children: use and interpretation].

Ezri J, Nydegger A.

Rev Med Suisse. 2011 Jan 12;7(277):69-70. French.

PMID:
21309180
9.

Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's disease.

Shaoul R, Sladek M, Turner D, Paeregaard A, Veres G, Wauters GV, Escher J, Dias JA, Lionetti P, Staino A, Kolho KL, de Ridder L, Nuti F, Cucchiara S, Sheva O, Levine A; ESPGHAN Porto IBD Group.

Inflamm Bowel Dis. 2012 Aug;18(8):1493-7. doi: 10.1002/ibd.21875. Epub 2012 Jan 24.

PMID:
22275268
10.

Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease.

Leach ST, Yang Z, Messina I, Song C, Geczy CL, Cunningham AM, Day AS.

Scand J Gastroenterol. 2007 Nov;42(11):1321-31.

PMID:
17852869
11.

Human calprotectin: effect of calcium and zinc on its secondary and tertiary structures, and role of pH in its thermal stability.

Yousefi R, Imani M, Ardestani SK, Saboury AA, Gheibi N, Ranjbar B.

Acta Biochim Biophys Sin (Shanghai). 2007 Oct;39(10):795-802.

12.

Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseases.

Holzinger D, Fassl SK, de Jager W, Lohse P, Röhrig UF, Gattorno M, Omenetti A, Chiesa S, Schena F, Austermann J, Vogl T, Kuhns DB, Holland SM, Rodríguez-Gallego C, López-Almaraz R, Arostegui JI, Colino E, Roldan R, Fessatou S, Isidor B, Poignant S, Ito K, Epple HJ, Bernstein JA, Jeng M, Frankovich J, Lionetti G, Church JA, Ong PY, LaPlant M, Abinun M, Skinner R, Bigley V, Sachs UJ, Hinze C, Hoppenreijs E, Ehrchen J, Foell D, Chae JJ, Ombrello A, Aksentijevich I, Sunderkoetter C, Roth J.

J Allergy Clin Immunol. 2015 Nov;136(5):1337-45. doi: 10.1016/j.jaci.2015.04.016. Epub 2015 May 27.

PMID:
26025129
13.

Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease.

Konikoff MR, Denson LA.

Inflamm Bowel Dis. 2006 Jun;12(6):524-34. Review.

PMID:
16775498
14.

Hyperzincemia with systemic inflammation: a heritable disorder of calprotectin metabolism with rheumatic manifestations?

Saito Y, Saito K, Hirano Y, Ikeya K, Suzuki H, Shishikura K, Manno S, Takakuwa Y, Nakagawa K, Iwasa A, Fujikawa S, Moriya M, Mizoguchi N, Golden BE, Osawa M.

J Pediatr. 2002 Feb;140(2):267-9.

PMID:
11865286
15.

Fecal calprotectin in pediatric inflammatory bowel disease: a systematic review.

Kostakis ID, Cholidou KG, Vaiopoulos AG, Vlachos IS, Perrea D, Vaos G.

Dig Dis Sci. 2013 Feb;58(2):309-19. doi: 10.1007/s10620-012-2347-5. Epub 2012 Aug 17. Review.

PMID:
22899243
16.

Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children.

Sidler MA, Leach ST, Day AS.

Inflamm Bowel Dis. 2008 Mar;14(3):359-66.

PMID:
18050298
17.

Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases.

Diamanti A, Colistro F, Basso MS, Papadatou B, Francalanci P, Bracci F, Muraca M, Knafelz D, De Angelis P, Castro M.

Inflamm Bowel Dis. 2008 Sep;14(9):1229-35. doi: 10.1002/ibd.20472.

PMID:
18398894
18.

Calprotectin - a pleiotropic molecule in acute and chronic inflammation.

Stríz I, Trebichavský I.

Physiol Res. 2004;53(3):245-53. Review.

19.

Fecal calprotectin in children with the enthesitis-related arthritis subtype of juvenile idiopathic arthritis.

Stoll ML, Punaro M, Patel AS.

J Rheumatol. 2011 Oct;38(10):2274-5. doi: 10.3899/jrheum.110508. No abstract available.

20.

Faecal calprotectin: a marker of inflammation throughout the intestinal tract.

Summerton CB, Longlands MG, Wiener K, Shreeve DR.

Eur J Gastroenterol Hepatol. 2002 Aug;14(8):841-5.

PMID:
12172403
Items per page

Supplemental Content

Write to the Help Desk